The clinical status of cadaveric renal transplant patients treated for 10 year with cyclosporine therapy

Clin Transplant. 1999 Aug;13(4):324-9. doi: 10.1034/j.1399-0012.1999.130408.x.

Abstract

In this paper we assessed the clinical status of 150 cadaveric renal transplant patients who received cyclosporine without interruption for 10 yr. The mean creatinine clearance was 59.2 +/- 15.71 at 1 yr and 55.6 +/- 24.91 mL/min at 10 yr (p = 0.039). Patients were subdivided into four quartiles according to the mean creatinine clearance at 1 yr. The 14 patients with the lowest quartile showed a significant decrease of creatinine clearance from the 1st to 10th year (from 31.5 +/- 5.83 to 24.8 +/- 14.00 mL/min; p = 0.038) while no difference between the mean creatinine clearance at 1 and at 10 yr was found in the other three quartiles. At 10 yr, 84.6% patients needed antihypertensive therapy, a rate similar to that seen at 1 yr (81.4%). The mean plasma cholesterol (253 +/- 57.8 mg/dL) and triglyceride (197 +/- 113.1 mg/dL) at 10 yr were similar to those found at +/- yr (243 +/- 48.2 and 201 +/- 143.0 mg/dL, respectively). Most patients have a high degree of rehabilitation 10 yr after uninterrupted cyclosporine therapy and all patients but 3 were able to work.

MeSH terms

  • Adult
  • Cadaver
  • Creatinine / metabolism
  • Cyclosporine / therapeutic use*
  • Diabetes Mellitus
  • Employment
  • Female
  • Follow-Up Studies
  • Graft Survival
  • Humans
  • Hypertension / drug therapy
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Function Tests
  • Kidney Transplantation* / adverse effects
  • Lipids / blood
  • Male
  • Time Factors
  • Tissue Donors*

Substances

  • Immunosuppressive Agents
  • Lipids
  • Cyclosporine
  • Creatinine